Nirmish Shah

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo et al. · The Lancet Haematology · 2019 · 315 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +13

Sickle cell disease complications: Prevalence and resource utilization

Nirmish Shah, Menaka Bhor, Lin Xie et al. · PLoS ONE · 2019 · 108 citations · Full text

Medicine, Health Care Management, Acute Care Medicine +12

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism

Neil A. Goldenberg, John M. Kittelson, Thomas C. Abshire et al. · JAMA · 2022 · 94 citations · Full text

Medicine, Hematology, Internal Medicine +17

Patients Welcome the Sickle Cell Disease Mobile Application to Record Symptoms<i>via</i>Technology (SMART)

Nirmish Shah, Jude Jonassaint, Laura M. De Castro · Hemoglobin · 2014 · 87 citations

Nursing, Health Care Management, Health Informatics +15

Usability and Feasibility of an mHealth Intervention for Monitoring and Managing Pain Symptoms in Sickle Cell Disease: The Sickle Cell Disease Mobile Application to Record Symptoms<i>via</i>Technology (SMART)

Charles R. Jonassaint, Nirmish Shah, Jude Jonassaint et al. · Hemoglobin · 2015 · 80 citations

Nursing, Health Informatics, Health Sciences +17